138 related articles for article (PubMed ID: 987925)
1. Changes in the concentration of adenohypophyseal prolactin and morphological manifestations in the adenohypophysis of lactating rats after administration of D-6-methyl-8-[beta-isopropylaminoethyl] ergoline-I.
Krejcí P; Marhan O; Ausková M; Rezábek K; Semonský M
Experientia; 1976 Oct; 32(10):1308-9. PubMed ID: 987925
[TBL] [Abstract][Full Text] [Related]
2. Effect of ergoline derivative VUFB-6638 on the adenohypophysial prolactin concentration in rats.
Krejcí P; Ausková M; Rezábek K; Bílek J; Semonský M
Endocrinol Exp; 1975 Jan; 9(1):68-72. PubMed ID: 6259
[TBL] [Abstract][Full Text] [Related]
3. Interaction of perphenazine and an ergoline derivative on oestrogen-induced adenohypophyseal growth.
Schreiber V; Pribyl T
Physiol Bohemoslov; 1977; 26(1):31-8. PubMed ID: 140398
[TBL] [Abstract][Full Text] [Related]
4. The effect of the ergoline derivative VUFB-6683 on the adenohypophysial prolactin concentration in rats.
Krejcí P; Ausková M; Rezábek K; Bílek J; Semonský M
Experientia; 1973 Oct; 29(10):1262-3. PubMed ID: 4796640
[No Abstract] [Full Text] [Related]
5. Analysis of suckling-induced changes in adenohypophyseal prolactin concentration in the lactating rat by three assay methods.
Nicoll CS; Mena F; Nichols CW; Green SH; Tai M; Russel SM
Acta Endocrinol (Copenh); 1976 Nov; 83(3):512-21. PubMed ID: 989994
[TBL] [Abstract][Full Text] [Related]
6. Effects of oestrogen and bromocryptine on in vivo secretion and mitosis in prolactin cells.
Lloyd HM; Meares JD; Jacobi J
Nature; 1975 Jun; 255(5508):497-8. PubMed ID: 1138203
[No Abstract] [Full Text] [Related]
7. The effects of D-6-methyl-8-[beta-isopropylaminoethyl] ergoline-I on the lactation in nursing rats.
Ausková M; Rezábek K; Cerný A; Krajcrová M; Semonský M
Experientia; 1976 Oct; 32(10):1310. PubMed ID: 987926
[No Abstract] [Full Text] [Related]
8. Inhibition by 2-Br alpha-ergocryptine-mesilate (CB-154) of suckling-induced pituitary prolactin depletion in lactating rats.
Flückiger E; Kovacs E
Experientia; 1974 Oct; 30(10):1173. PubMed ID: 4435126
[No Abstract] [Full Text] [Related]
9. Inhibition of prolactin by ergoline congeners.
Barfknecht CF; Rusterholz DB
J Med Chem; 1974 Mar; 17(3):308-12. PubMed ID: 4811226
[No Abstract] [Full Text] [Related]
10. Induction of oestrus and ovulation with an ergoline derivative, substance VUFB 6638, an inhibitor of prolaction secretion.
Ausková M; Rezábek K; Zikán V; Semonský M
Physiol Bohemoslov; 1974; 23(5):417-21. PubMed ID: 4278534
[No Abstract] [Full Text] [Related]
11. Two novel prolactin release-inhibiting 8 alpha-amino-ergolines.
Flückiger E; Briner U; Bürki HR; Marbach P; Wagner HR; Doepfner W
Experientia; 1979 Dec; 35(12):1677-8. PubMed ID: 520501
[TBL] [Abstract][Full Text] [Related]
12. Vinblastine-induced microtubular paracrystals in prolactin cells of anterior pituitary gland of lactating rats.
Shiino M; Rennels EG
Am J Anat; 1975 Nov; 144(3):399-405. PubMed ID: 1211375
[TBL] [Abstract][Full Text] [Related]
13. The effect of 2-bromo-alpha-ergocryptine and 2-chloro-alpha-methylergoline-8beta-acetonitrile (lergotrile mesylate) on the prolactin secretion of the ewe.
Hooley RD; Fell LR; Findlay JK
Acta Endocrinol (Copenh); 1977 Dec; 86(4):722-7. PubMed ID: 411304
[TBL] [Abstract][Full Text] [Related]
14. Effect of prolactin inhibitory agents on the ectopic anterior pituitary and the mammary gland in rats.
Gräf KJ; Horowski R; Etreby MF
Acta Endocrinol (Copenh); 1977 Jun; 85(2):267-78. PubMed ID: 325978
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of prolactin secretion by lergotrile mesylate: mechanism of action.
Clemens JA; Smalstig EB; Shaar CJ
Acta Endocrinol (Copenh); 1975 Jun; 79(2):230-7. PubMed ID: 166535
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the growth reaction of the rat adenohypophysis to oestrogen by an ergoline derivative.
Schreiber B; Pribýl T; Rohácová J
Physiol Bohemoslov; 1973; 22(1):11-7. PubMed ID: 4269742
[No Abstract] [Full Text] [Related]
17. Inhibition by an ergoline derivative (dopaminergic agonist) of oestradiol-induced adenohypophyseal growth and of the decrease in the hypothalamic ascorbic acid (HAA) concentration in rats.
Schreiber V; Pribyl T; Jahodová J
Physiol Bohemoslov; 1982; 31(2):97-100. PubMed ID: 6212960
[TBL] [Abstract][Full Text] [Related]
18. Prolactin secretion inhibition by a new 8alpha-amino-ergoline, CH 29-171.
Flückiger E; Briner U; Doepfner W; Kovacs E; Marbach P; Wagner HR
Experientia; 1978 Oct; 34(10):1330-2. PubMed ID: 570121
[No Abstract] [Full Text] [Related]
19. Dopamine agonistic potency of two novel prolactin release-inhibiting ergolines.
Markó M
Eur J Pharmacol; 1984 Jun; 101(3-4):263-6. PubMed ID: 6468500
[TBL] [Abstract][Full Text] [Related]
20. Influence of ergot alkaloids on pituitary prolactin and prolactin-dependent processes.
Floss HG; Cassady JM; Robbers JE
J Pharm Sci; 1973 May; 62(5):699-715. PubMed ID: 4574586
[No Abstract] [Full Text] [Related]
[Next] [New Search]
